Enhanced proliferation of CD8+ T cells in tumor was observed in response to radiation combined with dazostinag when compared with dazostinag or radiation used alone, demonstrating the potential of this combination for enhanced T-cell response (Fig. 1C and D). Here, CD8A is linked to neoplasm.